Literature DB >> 11836770

MRI detection of myocardial perfusion defects due to coronary artery stenosis with MS-325.

Dara L Kraitchman1, Bennett B Chin, Alan W Heldman, Meiyappan Solaiyappan, David A Bluemke.   

Abstract

PURPOSE: To assess the value of an intravascular, albumin-targeted contrast agent, MS-325, in visualizing myocardial ischemia with magnetic resonance imaging (MRI).
MATERIALS AND METHODS: Left anterior descending coronary artery (LAD) stenosis was created in 19 pigs using a closed-chest modified angioplasty technique. Myocardial ischemia was detected by first-pass, contrast-enhanced MRI at peak dipyridamole stress and was compared to Technetium-99m (Tc-99m) sestamibi single photon emission computed tomography (SPECT). Regional coronary blood flow was determined using microspheres.
RESULTS: Inducible myocardial ischemia with >40% reduction in stress myocardial blood flow was created in eight animals. An MRI defect, classified as > or=75% reduction in peak myocardial signal intensity in the affected territory, was detected in 92.3% of these animals. In the presence of mild coronary stenosis, there was uniform enhancement with MRI and tracer uptake by SPECT. Concordance of MRI and SPECT for detecting perfusion defects was 85%.
CONCLUSION: The pattern of prolonged and persistent MR hypoenhancement of the ischemic myocardial bed using MS-325, which is retained primarily in the vascular bed due to its albumin-binding properties, facilitates the detection of myocardial perfusion defects. Copyright 2002 Wiley‐Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11836770     DOI: 10.1002/jmri.10051

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  7 in total

1.  Steady-state free precession sequences in myocardial first-pass perfusion MR imaging: comparison with TurboFLASH imaging.

Authors:  Peter Hunold; Stefan Maderwald; Holger Eggebrecht; Florian M Vogt; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2003-11-26       Impact factor: 5.315

Review 2.  Magnetic resonance cardiac perfusion imaging-a clinical perspective.

Authors:  Peter Hunold; Thomas Schlosser; Jörg Barkhausen
Journal:  Eur Radiol       Date:  2006-05-03       Impact factor: 5.315

Review 3.  Myocardial perfusion imaging by cardiac magnetic resonance.

Authors:  Juerg Schwitter
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

4.  Dose response of the intravascular contrast agent gadofosveset trisodium in MR perfusion imaging of the myocardium using a quantitative evaluation.

Authors:  Sebastian Niedermayer; Steven Sourbron; Maria Prompona; Clemens Cyran; Maximilian Reiser; Armin Huber
Journal:  Int J Cardiovasc Imaging       Date:  2013-06-06       Impact factor: 2.357

5.  Leakage and water exchange characterization of gadofosveset in the myocardium.

Authors:  Octavia Bane; Daniel C Lee; Brandon C Benefield; Kathleen R Harris; Neil R Chatterjee; James C Carr; Timothy J Carroll
Journal:  Magn Reson Imaging       Date:  2013-12-07       Impact factor: 2.546

Review 6.  Assessment of myocardial ischemia and viability using cardiac magnetic resonance.

Authors:  Javier Sanz; Teresa Rius; Paola Kuschnir; Rafael Salguero Bodes; Michael Poon
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

Review 7.  Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art.

Authors:  Bernhard L Gerber; Subha V Raman; Krishna Nayak; Frederick H Epstein; Pedro Ferreira; Leon Axel; Dara L Kraitchman
Journal:  J Cardiovasc Magn Reson       Date:  2008-04-28       Impact factor: 5.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.